Colorectal cancer is the third most common cancer diagnosed in both men and women
The most reliable investigation for diagnosis of colorectal cancer is total colonoscopy.
However, the acceptance of this costly and invasive method is low. For a successful colorectal cancer screening program it is therefore necessary to use the next best screening tools
The ScheBo® • M2-PK Stool Test is a totally new approach for bowel cancer screening
tests. Previously, only non-specific tests for blood in the stool could be used to give an
indication of an existing bowel cancer or its precursors.
The main advantages of the ScheBo® • M2-PK Stool Test are:
• High sensitivity, specificity
• Not dependent on occult blood
• Detects bleeding or non-bleeding bowel polyps, especially >1cm & bleeding
or non-bleeding bowel tumours
• Not affected by specific foods & No special diet required
• No false results from haemorrhoids or other sources of blood in the bowel
• A single pea-sized sample is sufficient